Papers

10

Total Citations

145

H-Index

7

About

John Pfail is a urologic surgeon and researcher whose work focuses on optimizing perioperative care and advancing surgical techniques for genitourinary cancers, particularly bladder, prostate, and upper tract urothelial carcinoma. His most impactful contributions center on opioid-sparing protocols in robotic-assisted radical cystectomy—his 2019 prospective study on nonopioid pathways (34 citations) and subsequent 2021 implementation with intracorporeal diversion (16 citations) have helped reshape postoperative pain management. Pfail has also led large-scale comparative effectiveness studies, including a multinational propensity-matched analysis of open, laparoscopic, and robotic nephroureterectomy (30 citations), providing critical evidence on oncologic and perioperative outcomes. His work extends to anesthetics and cancer recurrence, as well as the emerging role of artificial intelligence in urologic imaging—his 2024 review on AI’s transformative potential in diagnosis and precision surgery (12 citations) signals a forward-looking research agenda. With over 140 total citations across ten key publications, Pfail has demonstrated consistent impact in urologic oncology, earning recognition for his contributions to evidence-based surgical practice and patient-centered outcomes.

Research Focus

Key Achievements

7
H-Index
10
Papers
145
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Prospective implementation of a nonopioid protocol for patients undergoing robot-assisted radical cystectomy with extracorporeal urinary diversion
34 citations · 2019
📈 Most Prolific Year: 2020 (3 Papers)
🤝 Key Collaborators: 96
🏛 Institutions: Icahn School of Medicine at Mount Sinai, Rutgers, The State University of New Jersey

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago